dividend

data

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

We are excited about the data and plan to submit the data for publication and peer reviewed medical journal in the near term.

$AVXL Australia trial data meets the gold standard.

Efficacy is likey overwhelming after seeing 👀  data details!

$AVXL  I am extremely bullish on the data .. the FDA can ask any sorts of questions

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Also clint said every time Blarcamesine data comes back it looks better and better. .

Anavex has significant 4 years of ph2/3  safety data with safety back to 2013 for Blarcamesine  .. anavex has full 3 endpoint trial and a placebo  .. it&#39;s obvious Anavex wins!!

So I think the data so far was encouraging,

business-result

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

Biocryst Pharmaceuticals Inc.

trading

$XBI $BCRX XBI trading at 2017 prices holy fuck

$BCRX Jon should have been investigated for insider trading and his pulled offering and his many many misleading statements of embezzlement of riches!

Don’t fall for their bullshit, let the dogs trade with themselves

Big Loser Alert: Trading today&#39;s -8.4% move in BIOCRYST PHARMACEUTICALS $BCRX https://wp.me/p5bLGB-iCRZ

You might have lost money on every trade and every move.

but the trading, at least in my mind, seems a bit strange, and a bit like its percolating,  and something is brewing, such as 9930 prelim data, or some other pr drop is coming.

$BCRX the options pricing on this ticker trading in five cent increments really chaps my ass.

Shorting like this should be 100% illegal in my opinion and falls under manipulation of fair trading!

executive

$BCRX  
 
man ceo scamhouse sucks royal ass 
 
lying prick 
 
💩💩💩💩💩

too bad $bcrx has that chicken shit ceo scamhouse.

if anyone in $xbi $ibb are looking for a bio with a pos lying scumbag ceo then look at 
 
$BCRX 
 
one of the worst anywhere 
 
thank me later

Board needs to act as ceo has mislead his shareholders deceitful action!

Your CEO and board are lightweight morons and your shares will continue to lose value.

$BCRX “what’s the value of that” - Jack shit When You’re CEO

Your CEO and board are fucking idiots who had a solid hand

Their fucking shares are underwater because you’re a shit CEO

premium

We have no premium because Stoney is a dumb cunt.

NOW EVEN WITH NEARLY 300M IN FUCKING REVS THESE WORTHLESS FUCKS ON THE BOD CANT GET ANYTHING DONE EXCEPT SPEND TONS OF CASH ON USELESS SHIT PROGRAMS IN THE PIPE INSTEAD OF MAKING US PROFITABLE WITH WHAT THEY HAVE AN SELLING AT A PREMIUM.

but saw the .47/per - even higher premium than my $13s!

$BCRX disappointing price action over the last 3 days, the only reason why this doesn’t bother me so much is the call premium!

$BCRX Took a 50k loss, I’m the fuck outta here.

You played people here all while you lined your pocket with their losses!

$BCRX For the first time in over 2 years I might be setting a stop loss on my remaining position, dang it

$BCRX Investing in Biotech should come with a WARNING:
Will cause hair loss, vomiting, Insomnia and alcohol addiction lol

When it’s bad, it’s very bad.

That is a loss of just 18 to 19% for a VERY volatile bio market sector in a historically VERY shitty bear market.

$BCRX looks like EOY will not be very good.. 13,75 it was 31-12-2021.. now we are at 10,65.. looks like 2022 will end with a pretty big YTY loss

$BCRX this stock is as frustrating as that Spain loss 😤

Carvana swung to an adjusted operating loss of $186 million compared to a $9 million profit a year ago.

YOU MORONS HAVEN’T DONE YOUR JOB THE PAST 2 YEARS IN FORCING STONEHOUSE’S HAND FOR A BUYOUT.

Or sell the damn company and let a real Pharma with real leadership do the job.

Btw they are doing a crappy job trying to play up the new compound, cuz it’s to early.

$BCRX damn its like they knew i was gone and didn&#39;t do SHIT jobs wise

$BCRX  May be a good day to pick up some oil stocks, support seems to be holding IMHO 
Lots of good dividend payers out there too.

$BCRX  
European stocks rose on Friday as investors took an optimistic view of a week of data releases that showed economies in Europe and the US were more robust than expected.

#1 Suddenly alot of positive accounts appear, promoting the company has solid data, solid sales

$BCRX Have strong feeling once 10013 data is out we are going places.

$BCRX This preliminary data on BCX10013 is pretty impressive.

$BCRX great 10013 data and 320+ projected rev

but it also seems like the good choice to do so seeing iptacopan data.

$BCRX This is actually a good buy at these levels.

Long term Bcrx should climb quarter after quarter until they align with projections billion plus!

Positive news with the early results of the new Factor D molecule 10013.

$BCRX 10% growth quarter over quarter considering flat q1 (as noted with ins payout sched) puts us at 326mil for the year.

Relative strength to SPY past 6 weeks, high growth 8 quarters straight.

$BCRX 10.5 is the new high for this first quarter.

$BCRX so they hit their Q4 numbers, had stellar phase IA results and guided for a 70Mil increase in revenue in 202e.

$BCRX sales doubled 4 quarter 70.7 million + 53% year over year..

Result - volume up about 36.5% over a normal day.

But, with our management, our scientists, and our derisked ORLADEYO keeping the revenues incoming and growing quarter after quarter after quarter.

Prem results in q1 and it will beat any drug in the mkt.

hold

My strat is way better then hold and get rich 😉

$BCRX  I&#39;ve really enjoyed this forum - going to hold at least my current 18k shares, forever.

Goldman Sachs Group, Inc.

scam

Grind The Federal Reserve in the garbage disposal.

$GS Investing in this scam stock is like playing a game of chance with your money.

$GS this garbage will underperform all day and close at 318

target

Bunch of rat bastards with pie in the sky price targets and manipulation

$GS scam cunts , they have the worse price targets t manipulation price action.

↳ Why are you paying to be in a Trading Room?

Goldman Sachs is under capitalized and illegally using client money for trading

$GS huge amounts of risky trading which they sucked at last quarter.

$GS 100% spam, lies, et al, not the first time fake dmj has been used, ignore, report this fraudster ron, he&#39;s no guru, my friends, good health and trading to all.

$GS sucks try banking, trading and investing with SoFi come over to $SOFI big banks suck!

$GS shares down -6% for the worst day in 364 trading days (a day shy of the anniversary). Pulling down other banks ($KBE)

analyst

Goldman Sachs missed analysts’ estimates on both the top and bottom lines, with loan loss provisions coming in higher than expected.

$GS traah pos, fk them corrupt scums fake price analyst

but you can’t be down $3.94B QoQ from last year when you have industry peers with less clout $JPM $BAC both pushing out over $2B in profits for the same quarter. Embarrassing.

$GS  atrocious quarter … these pigs overpay themselves richly no matter what their business is doing … no cost control in the compensation and benefits area … embarrassing fail as compared with rival Morgan Stanley

4th straight quarter of declining profits and these guys are heroes???!

$GOOD night $GS , at least we have a 9% dividend!

SBLK in particular will continue to pay large dividends,

Housing data is up for weeks, job market and economy is stronger then expected, while no available shares to short.

Goldman: “An improvement in US and global macro data has lifted the S&amp;P 500 by 8% YTD and leads us to lift our 3-month S&amp;P 500 target to 4000 (from 3600).

$AAPL earnings are not gonna be too strong if we base it of $GS data and sales data for product lines 
still great company

$SPY – after a shortened trading week, there are SOME bullish data points,

$SPY I love how $GS expectd the Feds to do what they say 😂 clowns .

$BTC.X $DKNG $GS $QQQ $SPY 
“The world is saying something” that’s a great quote. Cheers.

$QQQ $SPY $DIA $C $GS the banks are all backed with cash, so in my opinion there are no more problems.

$SPY $QQQ $GS well that was easy for bulls today.

$AABB ok new favorite one $AMC $APE.X $SPY $GS  notice the golden shovel

$SPY no rate hike next week $GS now said, very interesting.

bear

.Ready For A Nice Move $25+++ Lots Of Bear Meat Over There!!! DWAC

$GS I dont see too much more downside, bears are getting greedy, in one week we will be back by $360+

🐻❤😈 your 24x7 active short trader care bear specialist for profits  .

$GS tomorrow another bear victory 🐻🐻🐻🐻🐻🐻

Nice fade  on ER 50/50 bet bears got paid this time!

$GS where all my morning bears at 🐻🐻🐻🐻🐻🐻🐻🐻🐻🐻🐻

A nice bear rally next week and overall strength until gdp and end of month QT.

Top Stocks matching your search for "dividend data"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

BCRX

Biocryst Pharmaceuticals Inc.

-23.50%

$10.68 - $8.17

Mar, 16, 2023

GS

Goldman Sachs Group, Inc.

-15.26%

$374.40 - $317.28

Jan, 17, 2023

Jan, 17, 2023

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

BCRX

Biocryst Pharmaceuticals Inc.

-23.50%

$10.68 - $8.17

Mar, 16, 2023

GS

Goldman Sachs Group, Inc.

-15.26%

$374.40 - $317.28

Jan, 17, 2023

Jan, 17, 2023

Nov, 18, 2022